Bai Fu Zi (Typhonium Rhizome)

Chinese Herb Actions

Chinese Herb Dosage

• What is the typical dosage of Bai Fu Zi?

  Our record lists 3–5 grams of the processed tuber — and the word “processed” is the load-bearing part of that sentence. The fresh or unprocessed tuber is not used internally at any dose; it is a direct irritant that has caused documented acute poisoning by chewing alone. This is reference information about a professional-only, toxic herb, not a dose for anyone to act on.

  • Processed material only — pharmacopoeial preparation of Typhonii Rhizoma involves repeated treatment with adjuvants such as ginger, alum, licorice and quicklime; we note the existence of that requirement and deliberately give no method.
  • Fresh material is for external use at most — our own existing caution for this herb states that fresh Bai Fu Zi is toxic and used only externally.
  • Short courses in small doses — the formulas built on it, such as Qian Zheng San, are narrow and short-term by design rather than ongoing prescriptions.

  Sources: this site’s existing dosage and caution records for this herb; PMID 42271478, DOI 10.1186/s13020-026-01437-6 (Chinese Medicine 2026 systematic review of processing-induced detoxification, listing Typhonii Rhizoma and its multi-adjuvant processing); PMID 38311951, DOI 10.3760/cma.j.cn121094-20221215-00592 (acute poisoning from chewing the fresh tuber). Reference facts only — not a prescription.

Chinese Herb Contraindications & Cautions

• Are there cautions or contraindications for Bai Fu Zi?

  Bai Fu Zi is toxic, is contraindicated in pregnancy, and is a professional-only herb. Our existing cautions record states that it must not be used in pregnancy, not in yin-deficient heat patterns, not in heat stroke arising from Liver fire, and that fresh Bai Fu Zi is toxic and used only externally.

  • Contraindicated in pregnancy — absolute, in line with the toxic wind-phlegm herbs generally.
  • Not for yin-deficiency heat or Liver-fire patterns — it is warm and drying, so it aggravates the very patterns it may superficially seem to address.
  • Fresh or unprocessed material is not taken internally — acute poisoning has been reported from chewing the fresh tuber, with lip numbness, oral swelling and ulceration, uncontrollable salivation, painful and difficult swallowing, marked throat burning, rapid breathing and mild hypoxaemia. The reported patient recovered with supportive hospital care.
  • Do not substitute for, or confuse with, Fu Zi — see the notes section; the two herbs are different plants with different toxic mechanisms and different processing requirements.
  • Formula-level caution — our record for Qian Zheng San notes that two of its three ingredients are toxic and that the formula is contraindicated in pregnancy and intended for short-term use only.

  Sources: this site’s existing caution records for this herb and for Qian Zheng San; PMID 38311951, DOI 10.3760/cma.j.cn121094-20221215-00592 (case of acute poisoning from the fresh tuber). Neutral safety reference, not usage instructions.

Chinese Herb Toxicity & Overdose

• Moderate to high, and mechanistically specific: Bai Fu Zi’s toxicity is irritant rather than systemic-alkaloid, and it comes from two constituents acting together — needle-shaped calcium-oxalate crystals and a plant lectin. A 2026 systematic review of processing-induced detoxification in toxic Chinese medicines groups Typhonii Rhizoma with Pinellia and Arisaema as Araceae herbs whose harm arises from “mechanical injury caused by these toxic needle crystals and chemical damage caused by lectins,” the crystals being sharply pointed, rigid structures composed of calcium oxalate and protein.

  What the literature documents:

  • Acute mucosal injury — the 2024 poisoning case describes the characteristic Araceae picture after chewing the fresh tuber: numb lips, swollen and ulcerated oral mucosa, continuous salivation, difficulty swallowing, burning throat, shortness of breath and mild hypoxaemia, requiring oxygen, cardiac monitoring, debridement of necrotic oral mucosa, anti-infective and nutritional support.
  • Lectin-driven inflammation — Typhonium giganteum lectin has been shown in macrophage cell models to drive a pro-inflammatory response through reactive oxygen species and NF-κB signalling, and a separate study correlated the lectin’s pro-inflammatory role with macrophage activity. This gives a molecular account of the herb’s acute irritant toxicity.
  • Processing exists to remove it — multi-adjuvant processing is the documented reason the material can be used at all. We record that this is required and give no method.
  • It is not aconitine toxicity — nothing in this profile resembles the cardiac and neurological toxicity of Fu Zi, which is why treating advice about one herb as applicable to the other is unsafe.

  Sources: PMID 42271478, DOI 10.1186/s13020-026-01437-6 (needle crystals and lectins as the toxicity mechanism of Araceae medicinals; multi-adjuvant processing); PMID 38311951, DOI 10.3760/cma.j.cn121094-20221215-00592 (acute poisoning case); PMID 28880234, PMC 5618208, DOI 10.3390/toxins9090275 (Typhonium giganteum lectin, ROS and NF-κB); PMID 26617695, PMC 4637780 (lectin and macrophage). Reference safety information, not a description of use.

• This herb is considered toxic.
  (while some Chinese herbs are toxic, it must be noted that many come prepared, or are combined, to mitigate their toxicity)

Herb-Drug Interactions

• No controlled clinical herb–drug interaction studies exist for Bai Fu Zi. The practical interaction risk is not pharmacological but identification-related: because the name is one syllable from Fu Zi, and because “Baifuzi” is also used in the literature for an Aconitum species, a dispensing or record-keeping error can put a patient on an aconite alkaloid instead of an arum tuber. Any medication review that encounters “Bai Fu Zi” should establish which botanical material is actually meant before anything else. (Precautionary reference context flagged for practitioner confirmation, not a demonstrated interaction list.)

Western / Biomedical Research

Chinese Herb Clinical Studies & Research

Provided as research context — a summary of published biomedical study, not a therapeutic or medical claim.

• Is there modern research on Bai Fu Zi (Typhonium giganteum)?

  Yes — a modest but coherent laboratory literature, concentrated on the herb’s cerebrosides, its lectin, and its processing. There are no controlled human trials to report, and none of this constitutes evidence of clinical benefit.

  • Cerebrosides and neuroprotection (cell models) — a new cerebroside named typhonoside was first isolated from the tuber in 2001, and a 2017 study isolated two further new cerebrosides, typhonosides E and F, alongside eleven known analogues. All showed activity against glutamate-induced apoptosis in PC12 cells, with potency tracking fatty-acyl chain length; the most active compound modulated caspase-9, caspase-3, Bax and Bcl-2 expression. Cell-model work only, but it is at least chemically consistent with the herb’s traditional association with wind-stroke sequelae.
  • Lectin toxicology — the pro-inflammatory activity of Typhonium giganteum lectin via ROS and NF-κB signalling is the main mechanistic account of the herb’s acute irritancy (see the toxicity section).
  • Genus-level phytochemistry — a 2019 review surveys novel constituents and anticancer activities across the genus Typhonium, and a 2011 study reported that a supercritical-CO2 extract of the tubers induced apoptosis in a human hepatoma cell line through a ROS-mediated mitochondrial pathway. Laboratory findings, not therapeutic claims.
  • Botanical identity — the complete chloroplast genome of Typhonium giganteum was published in 2020, providing a molecular reference for authenticating the correct species — directly relevant given the naming ambiguity described in the notes section.
  • Processing science — the 2026 systematic review of processing-induced detoxification places Typhonii Rhizoma within a body of work establishing how attenuation of Araceae toxicity is achieved and verified.

  Sources: PMID 11783581, DOI 10.1080/10286020108040367 (typhonoside and other constituents); PMID 28394604, DOI 10.1021/acs.jnatprod.6b00954 (typhonosides E and F, neuroprotection in PC12 cells); PMID 28880234, PMC 5618208, DOI 10.3390/toxins9090275; PMID 31744445, DOI 10.2174/1389200220666191118102616 (phytochemistry and anticancer activity of the genus Typhonium); PMID 21959296, PMC 6264752, DOI 10.3390/molecules16108228 (SFE-CO2 extract, hepatoma cell apoptosis); PMID 33458030, PMC 7782031, DOI 10.1080/23802359.2020.1797571 (chloroplast genome); PMID 42271478, DOI 10.1186/s13020-026-01437-6. Research context, not a therapeutic claim.

Chinese Herb Notes

• Is Bai Fu Zi the same as Fu Zi (aconite)? No — and confusing them is dangerous

  Bai Fu Zi and Fu Zi are two entirely different herbs from two different plant families, and they are not interchangeable in any way. Bai Fu Zi is the tuber of Typhonium giganteum (Araceae, the arum family). Fu Zi is the processed lateral root of Aconitum carmichaelii (Ranunculaceae, the buttercup family). The names differ by a single syllable; the plants, the toxic constituents, the required processing and the clinical role differ completely. Both are toxic, in different ways — which is precisely why the confusion matters.

  Side by side, using the identity records held on this site:

  • Bai Fu Zi — Rhizoma Typhonii Gigantei; family Araceae; acrid, sweet, warm, toxic; Spleen and Stomach channels; classed among the warm herbs that transform phlegm-cold; its toxicity is irritant, from calcium-oxalate needle crystals and a lectin.
  • Fu Zi — Radix Lateralis Praeparatus Aconiti Carmichaeli; family Ranunculaceae; acrid, hot, toxic; Heart, Kidney and Spleen channels; classed among the herbs that warm the interior and expel cold; its toxicity is from diterpenoid alkaloids of the aconitine type, which are cardiotoxic and neurotoxic rather than merely irritant.

  Why the error is dangerous in both directions. The two herbs have different, non-transferable safety requirements. Aconite’s processing exists to hydrolyse aconitine-type alkaloids and reduce cardiac and neurological toxicity, and aconitine poisoning can be life-threatening. Typhonium’s processing exists to destroy irritant needle crystals and lectin, and its poisoning presents as oral and pharyngeal burning, swelling, ulceration, salivation and difficulty swallowing. Applying one herb’s dose, processing assumption or caution to the other removes exactly the protection that matters.

  Was “Bai Fu Zi” ever a different plant historically?

  Yes — and the ambiguity survives in the literature. A 2025 pharmacology review states plainly that Radix Aconiti Coreani (from Aconitum coreanum) and Rhizoma Typhonium (from Typhonium giganteum) are “collectively known as Baifuzi.” Chinese sources conventionally distinguish these as Guan Bai Fu Zi (the Aconitum coreanum material, associated with the northeast) and Yu Bai Fu Zi (the Typhonium material), but the undifferentiated name still appears in modern papers: a 2021 review lists a formula ingredient as “Baifuzi (Aconitum coreanum)” without qualification. Current Chinese pharmacopoeial practice and standard Western materia medica both take Bai Fu Zi to mean the Typhonium material, which is what our identity record specifies. Readers encountering “Bai Fu Zi” in an older or translated source should check which plant is meant, because Aconitum coreanum is a third distinct toxicity profile again — another aconite, not an arum.

  Is Bai Fu Zi related to Bai Zhu or Bai Shao?

  No. The shared “bai” (white) is a colour word, not a relationship. Bai Zhu is Rhizoma Atractylodis Macrocephalae, a non-toxic qi tonic. Bai Shao is Radix Albus Paeoniae Lactiflorae, a non-toxic blood tonic. Neither is toxic and neither has anything in common with Bai Fu Zi beyond the syllable.

  Flagged for the site editor, not changed here: our own identity record classifies this herb’s properties as including “Toxic,” and its cautions note that the fresh material is toxic, yet the record’s toxic/endangered flag is currently set to false. That looks inconsistent with the herb’s own data. We have not altered any identity field; this is reported for owner review.

  Sources: identity records for Bai Fu Zi, Fu Zi, Bai Zhu and Bai Shao held on this site; PMID 40606624, DOI 10.3389/fphar.2025.1579172 (Frontiers in Pharmacology 2025: Radix Aconiti Coreani and Rhizoma Typhonium “collectively known as Baifuzi”); PMID 34567415, DOI 10.1155/2021/9923331 (review listing “Baifuzi (Aconitum coreanum)” as a formula ingredient); PMID 28863163, PMC 5581188, DOI 10.1371/journal.pone.0184257 (chloroplast genomes confirming Aconitum coreanum and Aconitum carmichaelii as distinct species); PMID 33458030, PMC 7782031, DOI 10.1080/23802359.2020.1797571 (chloroplast genome of Typhonium giganteum, Araceae); PMID 42271478, DOI 10.1186/s13020-026-01437-6 (processing and toxicity mechanism of Typhonii Rhizoma).

This herb is considered toxic